Collage photo of Bishoy Morris Faltas and Yan Leyfman
Mar 30, 2025, 21:29
Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
Bishoy Morris Faltas, Chief Research Officer at Weill Cornell Medicine, shared a post on LinkedIn:
“Excited to share our new paper in collaboration with Fei Wang to develop a cutting-edge AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in the S1314 randomized clinical trial.
Full X-plainer here.”
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post by Bishoy Morris Faltas, adding:
“Innovative approach to utilize AI. Congratulations to Dr. Bishoy Morris Faltas and team of Weill Cornell Medicine.”
Authors: Zilong Bai et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20